Avacta News Feed

Avacta Group Plc making 'excellent progress' on lead programmes

Alastair Smith, chief executive of Avacta Group Plc ( LON:AVCT ), tells Proactive Investors their lead PD-L1 programme remains on track to deliver key pre-clinical milestones this year. Smith says they're also making “excellent progress” with a second immuno-oncology research project, a LAG3 blockade, which can be combined with...

Pages